Our novel findings demonstrated that GPX2 expression was inversely correlated with both the Ki67 labeling index and the expression of P53, a tumor suppressor gene, that is frequently overexpressed or amplified in invasive higher stage bladder cancer (Figure 3A-3K). This evidence concerns the gene TP53 and urinary bladder carcinoma.